• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病与心脏瓣膜病的病理生理学

Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease.

机构信息

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec city, Québec, Canada; Cardiology department, Expert Valve Center, Henri Mondor hospital, Créteil, France; INSERM unit U955, Team 8, Paris-Est Créteil University, Val-de-Marne, Créteil, France.

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec city, Québec, Canada.

出版信息

Can J Cardiol. 2019 Sep;35(9):1195-1207. doi: 10.1016/j.cjca.2019.05.028. Epub 2019 May 28.

DOI:10.1016/j.cjca.2019.05.028
PMID:31472817
Abstract

Valvular heart calcification is common in patients with chronic kidney disease (CKD), especially in those receiving hemodialysis therapy, and it is associated with poor prognosis. Furthermore, progression of valvular heart disease (VHD) and structural valve deterioration of bioprosthetic valves are faster in these patients. Mechanisms involved in the pathophysiology of VHD are similar between patients with and without impaired kidney function, but CKD is associated with a bone metabolism dysregulation, which might lead to a procalcifying phenotype within vessels and heart valves. CKD is also associated with left ventricular remodelling and dysfunction, which might contribute to increase the risk of heart failure and death in patients with VHD. Even if promising pharmacotherapeutic avenues are in development, no medical treatment can prevent or reduce the valvular calcific process. Patients with advanced CKD should undergo transthoracic echocardiography for detection of VHD, and if present, follow-up should be more frequent than what is recommended in the guidelines. Transcatheter valve replacement might be preferred over surgical replacement in patients with CKD and severe aortic valve stenosis.

摘要

心脏瓣膜钙化在慢性肾脏病(CKD)患者中很常见,尤其是接受血液透析治疗的患者,与预后不良有关。此外,这些患者的瓣膜性心脏病(VHD)进展和生物假体瓣膜的结构恶化更快。VHD 的病理生理学机制在肾功能受损和无肾功能受损的患者中相似,但 CKD 与骨代谢失调有关,这可能导致血管和心脏瓣膜内的促钙化表型。CKD 还与左心室重构和功能障碍有关,这可能会增加 VHD 患者心力衰竭和死亡的风险。即使有有前途的药物治疗途径正在开发中,也没有药物治疗可以预防或减少瓣膜钙化过程。晚期 CKD 患者应接受经胸超声心动图检查以检测 VHD,如果存在,随访应比指南推荐的更频繁。对于 CKD 和严重主动脉瓣狭窄患者,经导管瓣膜置换可能优于手术置换。

相似文献

1
Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease.慢性肾脏病与心脏瓣膜病的病理生理学
Can J Cardiol. 2019 Sep;35(9):1195-1207. doi: 10.1016/j.cjca.2019.05.028. Epub 2019 May 28.
2
Valvular heart disease in patients with chronic kidney disease.慢性肾脏病患者的心脏瓣膜病。
Herz. 2021 Jun;46(3):228-233. doi: 10.1007/s00059-020-05011-0. Epub 2021 Jan 4.
3
Valvular heart disease and calcification in CKD: more common than appreciated.慢性肾脏病中的瓣膜心脏病和钙化:比想象中更常见。
Nephrol Dial Transplant. 2020 Dec 4;35(12):2046-2053. doi: 10.1093/ndt/gfz133.
4
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病与心脏瓣膜病:改善全球肾脏病预后组织(KDIGO)争议会议的结论。
Kidney Int. 2019 Oct;96(4):836-849. doi: 10.1016/j.kint.2019.06.025.
5
[Valvular heart disease in patients with chronic kidney disease].[慢性肾脏病患者的心脏瓣膜病]
Internist (Berl). 2020 Apr;61(4):368-374. doi: 10.1007/s00108-019-00692-0.
6
Valvular Calcification in Chronic Kidney Disease.慢性肾脏病的瓣膜钙化。
Adv Chronic Kidney Dis. 2019 Nov;26(6):464-471. doi: 10.1053/j.ackd.2019.10.004.
7
Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects.慢性肾脏病对瓣膜性心脏病患者长期预后的影响。
Int Urol Nephrol. 2020 Nov;52(11):2161-2170. doi: 10.1007/s11255-020-02561-4. Epub 2020 Jul 14.
8
[Heart valve calcification in patients with chronic kidney disease].[慢性肾脏病患者的心脏瓣膜钙化]
Klin Med (Mosk). 2009;87(6):31-5.
9
Echocardiographic assessment of cardiac structure and function in chronic renal disease.慢性肾病心脏结构和功能的超声心动图评估
J Echocardiogr. 2019 Sep;17(3):115-122. doi: 10.1007/s12574-019-00436-x. Epub 2019 Jul 8.
10
Clinical Benefit of Valvular Surgery in Patients with Chronic Kidney Disease.
Int Heart J. 2018 Jul 31;59(4):759-765. doi: 10.1536/ihj.17-460. Epub 2018 Jun 20.

引用本文的文献

1
Cardiac evaluation in patients awaiting kidney transplant-position statement of the Cardiological Society of India and Indian Society of Nephrology.印度心脏病学会和印度肾脏病学会关于等待肾移植患者心脏评估的立场声明
Indian Heart J. 2025 May-Jun;77(3):204-212. doi: 10.1016/j.ihj.2025.03.012. Epub 2025 Mar 25.
2
Rethinking Mitral Annular Calcification and Its Clinical Significance: From Passive Process to Active Pathology.重新审视二尖瓣环钙化及其临床意义:从被动过程到主动病变
J Pers Med. 2024 Aug 25;14(9):900. doi: 10.3390/jpm14090900.
3
Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model.
吡格列酮治疗可减轻慢性肾病模型中心血管生物假体的退变。
Front Pharmacol. 2024 Aug 8;15:1412169. doi: 10.3389/fphar.2024.1412169. eCollection 2024.
4
Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.慢性肾脏病特异性心血管疾病的新视角
Int J Mol Sci. 2024 Feb 24;25(5):2658. doi: 10.3390/ijms25052658.
5
In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study.慢性和终末期肾病患者经导管主动脉瓣置换术的院内转归:全国数据库研究。
BMC Cardiovasc Disord. 2024 Jan 3;24(1):21. doi: 10.1186/s12872-023-03684-z.
6
Echocardiographic manifestations in end-stage renal disease.终末期肾病的超声心动图表现。
Heart Fail Rev. 2024 Mar;29(2):465-478. doi: 10.1007/s10741-023-10376-5. Epub 2023 Dec 10.
7
Determinants of Aortic Stenosis Progression in Bicuspid and Tricuspid Aortic Valves.二叶式和三叶式主动脉瓣主动脉瓣狭窄进展的决定因素
CJC Pediatr Congenit Heart Dis. 2022 Jul 7;1(4):184-192. doi: 10.1016/j.cjcpc.2022.06.004. eCollection 2022 Aug.
8
Progression of valve heart disease in a cohort of patients undergoing renal replacement therapy.接受肾脏替代治疗的患者队列中心脏瓣膜病的进展。
J Bras Nefrol. 2024 Apr-Jun;46(2):e20230036. doi: 10.1590/2175-8239-JBN-2023-0036en.
9
Prediction of Heart Disease Based on Machine Learning Using Jellyfish Optimization Algorithm.基于使用水母优化算法的机器学习的心脏病预测
Diagnostics (Basel). 2023 Jul 17;13(14):2392. doi: 10.3390/diagnostics13142392.
10
An Approach for Cardiac Coronary Detection of Heart Signal Based on Harris Hawks Optimization and Multichannel Deep Convolutional Learning.基于哈里斯鹰优化和多通道深度卷积学习的心脏信号冠状动脉检测方法。
Comput Intell Neurosci. 2022 Jul 30;2022:7276028. doi: 10.1155/2022/7276028. eCollection 2022.